Massaro George's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed May 15, 2025
- Accession no.
- 0001127602-25-014486
- Filed
- May 15, 2025
- Trade date
- May 14, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $19.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Massaro GeorgeCIK 0001221496 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Common Stock | SSaleDisposed | −91 | $139.95F1 | −$12,735.45 | 5,764 | Direct | |
| May 14, 2025 | Common Stock | SSaleDisposed | −21 | $140.78F2 | −$2,956.38 | 5,743 | Direct | |
| May 14, 2025 | Common Stock | SSaleDisposed | −14 | $141.85F3 | −$1,985.9 | 5,729 | Direct | |
| May 14, 2025 | Common Stock | SSaleDisposed | −7 | $143.77F4 | −$1,006.39 | 5,722 | Direct | |
| May 14, 2025 | Common Stock | SSaleDisposed | −7 | $145.54F5 | −$1,018.78 | 5,715 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $139.47 to $140.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $140.52 to $141.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $141.80 to $141.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $143.70 to $143.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Referenced by the price of 1 transaction in Table I.
- F5
This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Referenced by the price of 1 transaction in Table I.